Table S3.
Repeated freeze–thaw stability test of DM-NCTD (n=5)
| Sample | RSD (%)
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| One cycle (μg/mL)
|
Two cycles (μg/mL)
|
Three cycles (μg/mL)
|
|||||||
| 0.1 | 1 | 5 | 0.1 | 1 | 8 | 0.1 | 1 | 5 | |
| Heart | 4.3 | 8.1 | 5.7 | 6 | 10.3 | 11.5 | 8.3 | 12.4 | 6.2 |
| Liver | 5.2 | 9.5 | 10.1 | 6.3 | 8.3 | 8 | 7.3 | 10.4 | 7 |
| Spleen | 8.9 | 5.3 | 8.2 | 10.6 | 7.3 | 5.7 | 8 | 12.4 | 5.6 |
| Lung | 10.7 | 9.4 | 10.1 | 5.3 | 8.5 | 7.4 | 9.2 | 12.8 | 8.1 |
| Kidney | 7.9 | 5.8 | 3.9 | 11.4 | 8.2 | 7.8 | 8.3 | 10.7 | 4.6 |
| Tumor | 12.6 | 10.9 | 11.4 | 12.7 | 9.8 | 7.8 | 9.8 | 10.5 | 13.6 |
Abbreviations: DM, diacid metabolite; NCTD, norcantharidin; RSD, relative standard deviation.